Effect of Sucralfate on Gastric Permeability in an Ex Vivo Model of Stress-related Mucosal Disease in Dogs

Overview

Journal J Vet Intern Med

Specialties General Medicine
Veterinary Medicine

Date 2018 Feb 21

PMID 29460464

Citations 4

Authors

Tracy L Hill

B Duncan X Lascelles

Anthony T Blikslager

Affiliations

Soon will be listed here.

Abstract

Background: Sucralfate is a gastroprotectant with no known systemic effects. The efficacy of sucralfate for prevention and treatment of stress-related mucosal diseases (SRMD) in dogs is unknown.

Hypothesis/objectives: To develop a canine ex vivo model of SRMD and to determine the effect of sucralfate on mucosal barrier function in this model.

Animals: Gastric antral mucosa was collected immediately postmortem from 29 random-source apparently healthy dogs euthanized at a local animal control facility.

Methods: Randomized experimental trial. Sucralfate (100 mg/mL) was applied to ex vivo canine gastric mucosa concurrent with and after acid injury. Barrier function was assessed by measurement of transepithelial electrical resistance (TER) and radiolabeled mannitol flux.

Results: Application of acidified Ringers solution to the mucosal side of gastric antrum caused a reduction in gastric barrier function, and washout of acidified Ringers solution allowed recovery of barrier function (TER: 34.0 ± 2.8% of control at maximum injury, 71.3 ± 5.5% at recovery, P < .001). Sucralfate application at the time of injury or after injury significantly hastened recovery of barrier function (TER: 118.0 ± 15.2% of control at maximum injury, P < .001 and 111.0 ± 15.5% at recovery, P = .35).

Conclusions And Clinical Importance: Sucralfate appeared effective at restoring defects in gastric barrier function induced by acid and accelerating repair of tissues subjected to acid in this model, suggesting that sucralfate could have utility for the treatment and prevention of SRMD in dogs.

Citing Articles

Clinical observation of magnesium aluminum carbonate combined with rabeprazole-based triple therapy in the treatment of helicobacter pylori-positive gastric ulcer associated with hemorrhage.

Zhou P, Gao L, Wang L, Zhang Y, Song W, Hao Y Pak J Med Sci. 2022; 38(5):1271-1277.

PMID: 35799719 PMC: 9247804. DOI: 10.12669/pjms.38.5.5174.

Clinical Management of Gastrointestinal Disease in the Common Marmoset (Callithrix jacchus).

Fitz C, Goodroe A, Wierenga L, Mejia A, Simmons H ILAR J. 2021; 61(2-3):199-217.

PMID: 33989417 PMC: 9214573. DOI: 10.1093/ilar/ilab012.

ACVIM consensus statement: Support for rational administration of gastrointestinal protectants to dogs and cats.

Marks S, Kook P, Papich M, Tolbert M, Willard M J Vet Intern Med. 2018; 32(6):1823-1840.

PMID: 30378711 PMC: 6271318. DOI: 10.1111/jvim.15337.

Effect of sucralfate on gastric permeability in an ex vivo model of stress-related mucosal disease in dogs.

Hill T, Lascelles B, Blikslager A J Vet Intern Med. 2018; 32(2):670-678.

PMID: 29460464 PMC: 5866966. DOI: 10.1111/jvim.15076.

References

Huang J, Cao Y, Liao C, Wu L, Gao F . Effect of histamine-2-receptor antagonists versus sucralfate on stress ulcer prophylaxis in mechanically ventilated patients: a meta-analysis of 10 randomized controlled trials. Crit Care. 2010; 14(5):R194. PMC: 3219301. DOI: 10.1186/cc9312. View

Matsuu-Matsuyama M, Shichijo K, Okaichi K, Nakayama T, Nakashima M, Uemura T . Protection by polaprezinc against radiation-induced apoptosis in rat jejunal crypt cells. J Radiat Res. 2008; 49(4):341-7. DOI: 10.1269/jrr.07114. View

Tolbert K, Bissett S, King A, Davidson G, Papich M, Peters E . Efficacy of oral famotidine and 2 omeprazole formulations for the control of intragastric pH in dogs. J Vet Intern Med. 2010; 25(1):47-54. DOI: 10.1111/j.1939-1676.2010.0651.x. View

Buendgens L, Bruensing J, Matthes M, Duckers H, Luedde T, Trautwein C . Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea. J Crit Care. 2014; 29(4):696.e11-5. DOI: 10.1016/j.jcrc.2014.03.002. View

Wooten J, Blikslager A, Marks S, Mac Law J, Graeber E, Lascelles B . Effect of nonsteroidal anti-inflammatory drugs with varied cyclooxygenase-2 selectivity on cyclooxygenase protein and prostanoid concentrations in pyloric and duodenal mucosa of dogs. Am J Vet Res. 2009; 70(10):1243-9. DOI: 10.2460/ajvr.70.10.1243. View

Cook D, Heyland D, Griffith L, Cook R, Marshall J, Pagliarello J . Risk factors for clinically important upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. Crit Care Med. 2000; 27(12):2812-7. DOI: 10.1097/00003246-199912000-00034. View

Monnig A, Prittie J . A review of stress-related mucosal disease. J Vet Emerg Crit Care (San Antonio). 2012; 21(5):484-95. DOI: 10.1111/j.1476-4431.2011.00680.x. View

Blikslager A, Zimmel D, Young K, Campbell N, Little D, Argenzio R . Recovery of ischaemic injured porcine ileum: evidence for a contributory role of COX-1 and COX-2. Gut. 2002; 50(5):615-23. PMC: 1773210. DOI: 10.1136/gut.50.5.615. View

Krag M, Perner A, Wetterslev J, Wise M, Borthwick M, Bendel S . Stress ulcer prophylaxis in the intensive care unit: an international survey of 97 units in 11 countries. Acta Anaesthesiol Scand. 2015; 59(5):576-85. DOI: 10.1111/aas.12508. View

10.

Peura D, Johnson L . Cimetidine for prevention and treatment of gastroduodenal mucosal lesions in patients in an intensive care unit. Ann Intern Med. 1985; 103(2):173-7. DOI: 10.7326/0003-4819-103-2-173. View

11.

Stupak D, Abdelsayed G, Soloway G . Motility disorders of the upper gastrointestinal tract in the intensive care unit: pathophysiology and contemporary management. J Clin Gastroenterol. 2012; 46(6):449-56. DOI: 10.1097/MCG.0b013e31824e14c1. View

12.

Kato S, Nishiwaki H, Konaka A, Takeuchi K . Mucosal ulcerogenic action of monochloramine in rat stomachs: effects of polaprezinc and sucralfate. Dig Dis Sci. 1997; 42(10):2156-63. DOI: 10.1023/a:1018847324172. View

13.

Takahashi S, Okabe S . Effects of sucralfate and its components on indomethacin-induced damage to cultured rabbit gastric mucosal cells. J Physiol Pharmacol. 1996; 47(4):611-9. View

14.

Takeda S, Sato N, Tomaru T . Haemodynamic and splanchnic organ blood flow responses during sevoflurane-induced hypotension in dogs. Eur J Anaesthesiol. 2002; 19(6):442-6. DOI: 10.1017/s0265021502000704. View

15.

Hill T, Lascelles B, Blikslager A . Effect of sucralfate on gastric permeability in an ex vivo model of stress-related mucosal disease in dogs. J Vet Intern Med. 2018; 32(2):670-678. PMC: 5866966. DOI: 10.1111/jvim.15076. View

16.

KuKanich K, KuKanich B, Harris A, Heinrich E . Effect of sucralfate on oral minocycline absorption in healthy dogs. J Vet Pharmacol Ther. 2014; 37(5):451-6. DOI: 10.1111/jvp.12116. View

17.

Shorrock C, Rees W . Effect of sucralfate on human gastric bicarbonate secretion and local prostaglandin E2 metabolism. Am J Med. 1989; 86(6A):2-4. DOI: 10.1016/0002-9343(89)90148-4. View

18.

Swann J, Maunder C, Roberts E, McLauchlan G, Adamantos S . Prevalence and risk factors for development of hemorrhagic gastro-intestinal disease in veterinary intensive care units in the United Kingdom. J Vet Emerg Crit Care (San Antonio). 2015; 26(3):419-27. DOI: 10.1111/vec.12434. View

19.

Mowat C, Williams C, Gillen D, Hossack M, Gilmour D, Carswell A . Omeprazole, Helicobacter pylori status, and alterations in the intragastric milieu facilitating bacterial N-nitrosation. Gastroenterology. 2000; 119(2):339-47. DOI: 10.1053/gast.2000.9367. View

20.

Lagoa C, de Figueiredo L, Cruz Jr R, Silva E, Silva M . Effects of volume resuscitation on splanchnic perfusion in canine model of severe sepsis induced by live Escherichia coli infusion. Crit Care. 2004; 8(4):R221-8. PMC: 522840. DOI: 10.1186/cc2871. View